Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Video
The Role of Potassium-Binding Agents in Treating Hyperkalemia
Dr. Cary Boyd-Shiwarski explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.
Pharmacy Times spoke to Dr. Cary Boyd-Shiwarski about her session at the ASN 2021 conference titled "Mechanisms of Potassium Handling in CKD."
Boyd explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.
Related Videos
Personalized Prevention: Identifying At-Risk Patients With Image-Based Screening
APhA 2025: Empowering Pharmacy Leaders With Mindful Self-Care Strategies
Sotatercept Demonstrates Its Potential in the Phase 3 ZENITH Trial
FINEARTS-HF Analysis: How Liver Biomarkers Influence Heart Failure Risk
Semaglutide and Cardiovascular Risk Reduction: What the Latest Data Tell Us
New Data Highlights Abelacimab’s Safety Advantage in Atrial Fibrillation
Exploring the Vascular Benefits of Semaglutide in Peripheral Artery Disease
APhA 2025: Building Pharmacy's Future With Mentorship, Advocacy, and Professional Development
APhA 2025: Empowering Pharmacy Leaders by Navigating Challenges and Personal Boundaries
APhA 2025: Training Pharmacy Technicians as Community Health Workers
Related Content
